Not all peptides are restricted. Here's the breakdown you actually need. The FDA's Category 2 classification affects specific compounded peptides BPC 157, TB 500, CJC 1295 Ipamorelin, AOD 9604, Epithalon, Selank, Semax. Others like Sermorelin AOD 9604 5mg (Spray) Modified Aminos Peptide Therapy Weight Loss in Connecticut AOD 9604 Tesamorelin Dr Sobo The FDA is reconsidering how it regulates compounded peptides and the implications are significant for access, safety, and clarity. Right now, the peptide landscape includes approved therapeutics, compounds in active clinical The FDA has repeatedly flagged AOD 9604 as a compound of concern. It was placed on the Category 2 list in 2023 bulk drug substances in compounding that may present significant